Laboratori Fundacio Dau Pharmadox Healthcare Limited
PolandAll drugs from this manufacturer
-
In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 86.48 mg ATC: B01AE07
-
The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 126.83 mg ATC: B01AE07
-
In adults, it is used to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of recurrence of blood clots in the veins of the legs and lungs. In children, the medicine is used for the treatment and prevention of recurrence of blood clots.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 172.95 mg ATC: B01AE07
-
In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, this medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 86.48 mg ATC: B01AE07
-
The medicine is used in adults to prevent blood clots after hip or knee surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, it is used to treat blood clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 126.83 mg ATC: B01AE07
-
The medicine is used in adults to prevent the formation of blood clots in the brain and other vessels (in atrial fibrillation with additional risk) and to treat and prevent the recurrence of clots in the veins of the legs and lungs. In children, it is used to treat clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 172.95 mg ATC: B01AE07